In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading

---
identifier: "/us/fr/2013-28447"
source: "fr"
legal_status: "authoritative_unofficial"
title: "In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading"
title_number: 0
title_name: "Federal Register"
section_number: "2013-28447"
section_name: "In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading"
positive_law: false
currency: "2013-11-23"
last_updated: "2013-11-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "SECURITIES AND EXCHANGE COMMISSION"
document_number: "2013-28447"
document_type: "notice"
publication_date: "2013-11-23"
agencies:
  - "SECURITIES AND EXCHANGE COMMISSION"
---


#  In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pure H20 Bio-Technologies, Inc. because questions have arisen as to its operating status, if any.

The Commission is of the opinion that the public interest and the protection of the investors require a suspension of trading in the securities of the above-listed company.

Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST on November 22, 2013, through 11:59 p.m. EST on December 6, 2013.

By the Commission.

Jill M. Peterson,

Assistant Secretary,